Drug-induced lupus anticoagulants and antiphospholipid antibodies

Current Rheumatology Reports

Volumn 14, Issue 1, 2012, Pages 71-78

  Dlott, Jeffrey S ^a   Roubey, Robert A S ^b  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Antiphospholipid syndrome; Circulating inhibitors; Drug induced; Lupus anticoagulants; Thrombosis

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; CHLORPROMAZINE; CLOZAPINE; DOXEPIN; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERLEUKIN 2; LUPUS ANTICOAGULANT; METHOTREXATE; NEUROLEPTIC AGENT; PHENOTHIAZINE DERIVATIVE; PHENYTOIN; PHOSPHOLIPID ANTIBODY; PROCAINAMIDE; PYRIMETHAMINE PLUS SULFADOXINE; QUINIDINE; QUININE; TUMOR NECROSIS FACTOR INHIBITOR; VALPROIC ACID;

ADENOCARCINOMA; ANEMIA; ANKYLOSING SPONDYLITIS; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTHRALGIA; AUTOIMMUNE DISEASE; BLOOD CLOTTING PARAMETERS; BRAIN ISCHEMIA; COMBINATION CHEMOTHERAPY; COOMBS TEST; DEEP VEIN THROMBOSIS; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG WITHDRAWAL; EFFUSION; FALSE POSITIVE RESULT; GRANULOMATOSIS; HEMOPHILIA; HUMAN; IMMUNOTHERAPY; JOINT STIFFNESS; LUNG DISEASE; LUNG EMBOLISM; LUPUS LIKE SYNDROME; MELANOMA; MICROSCOPIC POLYANGIITIS; MONOTHERAPY; NONHUMAN; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PLEURISY; PLEURITIC PAIN; REVIEW; RHEUMATOID ARTHRITIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SIDE EFFECT; SINGLE DRUG DOSE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOSIS; TISSUE THROMBOPLASTIN INHIBITION TEST; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; HUMANS; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 84857062051     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-011-0227-1     Document Type: Review

References (93)

1. CL Conley RC Hartmann 1952 A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus J Clin Invest 31 621 622
2. SS Shapiro 1996 The lupus anticoagulant/antiphospholipid syndrome Annu Rev Med 47 533 553 8712801 10.1146/annurev.med.47.1.533 1:CAS:528: DyaK28XitlSntbs%3D (Pubitemid 26138909)
3. K Lechner 1974 Acquired inhibitors in nonhemophilic patients Haemostasis 3 65 93 4613626 1:STN:280:DyaE2M%2Fns1WrsQ%3D%3D
4. EJW Bowie JH Thompson Jr CA Pascuzzi CA Owen Jr 1963 Thrombosis in systemic lupus erythematosus despite circulating anticoagulants J Lab Clin Med 62 416 430 14061973 1:STN:280:DyaF2c%2FhvFKjsg%3D%3D
5. DI Feinstein SI Rapaport 1972 Acquired inhibitors of blood coagulation Prog Hemostas Thromb 1 75 95 1:CAS:528:DyaE3sXhsFOnsbo%3D
6. HA Schroeder JD Morrow HM Perry Jr 1953 Studies on the control of hypertension by hyphex. I. Effects on blood pressure Circulation 8 5 672 680 13106889 1:STN:280:DyaG2c%2Fislyjug%3D%3D
7. TT Lindqvist 1957 Lupus erythematosus disseminatus after administration of mesantoin; report of two cases Acta Med Scand 158 2 131 138 13457840 10.1111/j.0954-6820.1957.tb15754.x 1:STN:280:DyaG1c%2FgtVCgsQ%3D%3D
8. AT Ladd 1962 Procainamide-induced lupus erythematosus N Engl J Med 267 1357 1358 13927984 10.1056/NEJM196212272672608 1:STN:280:DyaF387hvFKhtw%3D%3D
9. AT Borchers CL Keen ME Gershwin 2007 Drug-induced lupus Ann N Y Acad Sci 1108 166 182 17893983 10.1196/annals.1422.019 1:CAS:528:DC%2BD2sXhtVSqtr%2FK (Pubitemid 47528730)
10. MA Schleider RL Nachman EA Jaffe M Coleman 1976 A clinical study of the lupus anticoagulant Blood 48 4 499 509 963290 1:CAS:528:DyaE28XlvFSgtLw%3D
11. WR Bell GR Boss JS Wolfson 1977 Circulating anticoagulant in the procainamide-induced lupus syndrome Arch Intern Med 137 10 1471 1473 921427 10.1001/archinte.1977.03630220099024 1:STN:280:DyaE1c%2FjvFWltw%3D%3D (Pubitemid 9037748)
12. S Davis BC Furie JH Griffin B Furie R Willey 1978 Circulating inhibitors of blood coagulation associated with procainamide-induced lupus erythematosus Am J Hematol 4 4 401 407 717399 10.1002/ajh.2830040411 1:STN:280: DyaE1M%2FlvFKjsA%3D%3D (Pubitemid 9066774)
13. DK Galanakis J Newman D Summers 1978 Circulating thrombin time anticoagulant in a procainamide-induced syndrome JAMA 239 18 1873 1874 642115 10.1001/jama.1978.03280450045022 1:STN:280:DyaE1c7ltl2rtg%3D%3D (Pubitemid 8322876)
14. JR Mueh KD Herbst SI Rapaport 1980 Thrombosis in patients with the lupus anticoagulant Ann Intern Med 92 156 159 7352719 1:STN:280:DyaL3c7gslKqsw%3D%3D (Pubitemid 10141570)
15. RL Edwards ME Rick CJ Wakem 1981 Studies on a circulating anticoagulant in procainamide-induced lupus erythematosus Arch Intern Med 141 12 1688 1690 6171218 10.1001/archinte.1981.00340130126029 1:STN:280:DyaL38%2FmslWlsw%3D%3D (Pubitemid 12234080)
16. MJ Sanfelippo CJ Drayna 1982 Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis Am J Clin Pathol 77 275 279 6803570 1:STN:280:DyaL387nvFeruw%3D%3D (Pubitemid 12187438)
17. DC O'Brien SK Shimomura 1984 Procainamide and the lupus anticoagulant Drug Intell Clin Pharm 18 971 (Pubitemid 15175187)
18. DA Gastineau FJ Kazmier WL Nichols EJ Bowie 1985 Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases Am J Hematol 19 265 275 3925759 10.1002/ajh.2830190308 1:STN:280:DyaL2M3kvVCmuw%3D%3D (Pubitemid 15033408)
19. HJ Day R Cherrey D O'Hara J Carebello 1987 Incidence of procainamide-induced anticoagulant Thromb Haemost 58 394 Ref Type: Abstract
20. MT Weber WG Hocking 1988 Procainamide induced lupus anticoagulant Wis Med J 87 9 30 32 3142154 1:STN:280:DyaL1M%2FksFyqsw%3D%3D
21. MR Heyman RH Flores BB Edelman NH Carliner 1988 Procainamide-induced lupus anticoagulant South Med J 81 7 934 936 3134699 10.1097/00007611-198807000- 00035 1:STN:280:DyaL1c3nsl2rtg%3D%3D
22. GC Li CS Greenberg MS Currie 1988 Procainamide-induced lupus anticoagulants and thrombosis South Med J 81 2 262 264 3124275 10.1097/00007611-198802000-00029 1:STN:280:DyaL1c7islaktw%3D%3D (Pubitemid 18064506)
23. PA Schlesinger LA Peterson 1988 Procainamide-associated lupus anticoagulants and thrombotic events Arthritis Rheum 31 S54 Ref Type: Abstract
24. RA Asherson J Zulman GR Hughes 1989 Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies Ann Rheum Dis 48 232 235 2494958 10.1136/ard.48.3.232 1:STN:280:DyaL1M7pt1Gltw%3D%3D (Pubitemid 19072001)
25. M Kushner N Simonian 1989 Lupus anticoagulants, anticardiolipin antibodies, and cerebral ischemia Stroke 20 225 229 2493172 10.1161/01.STR.20.2. 225 1:STN:280:DyaL1M7ks1Okug%3D%3D (Pubitemid 19057980)
26. AF List DC Doll 1989 Thrombosis associated with procainamide-induced lupus anticoagulant Acta Haematol 82 1 50 52 2505475 10.1159/000205279 1:STN:280:DyaL1MzntV2gtw%3D%3D (Pubitemid 19223737)
27. JE Humphries 1996 Persistent procainamide-associated lupus anticoagulant Clin Hemost Rev 10 13
28. JT Merrill C Shen M Gugnani RG Lahita AB Mongey 1997 High prevalence of antiphospholipid antibodies in patients taking procainamide J Rheumatol 24 6 1083 1088 9195513 1:CAS:528:DyaK2sXktlOksr0%3D (Pubitemid 27250113)
29. NJ Freeman L Fajardo A Carvalho 1995 Simultaneous procainamide-induced immune thrombocytopenia and lupus anticoagulant Am J Hematol 48 2 133 134 7847333 1:STN:280:DyaK2M7kvF2rtA%3D%3D
30. H Kameda T Mimori J Kaburaki T Fujii T Takahashi M Akaishi, et al. 1998 Systemic sclerosis complicated by procainamide-induced lupus and antiphospholipid syndrome Br J Rheumatol 37 11 1236 1239 9851277 10.1093/rheumatology/37.11.1236 1:STN:280:DyaK1M%2Fms1KjsA%3D%3D
31. DA Triplett JT Brandt KA Musgrave CA Orr 1988 The relationship between lupus anticoagulants and antibodies to phospholipid JAMA 259 550 554 3121871 10.1001/jama.1988.03720040042024 1:STN:280:DyaL1c%2FptFaltg%3D%3D
32. TS Walker DA Triplett N Javed K Musgrave 1988 Evaluation of lupus anticoagulants: antiphospholipid antibodies, endothelium associated immunoglobulin, endothelial prostacyclin secretion, and antigenic protein S levels Thromb Res 51 267 281 2972088 10.1016/0049-3848(88)90104-1 1:STN:280:DyaL1M%2FhvF2qtA%3D%3D
33. LP Clyne LR Farber RL Chopyk 1989 Procainamide-induced circulating anticoagulants in a congenitally-deficient factor XI patient Folia Haematol Int Mag Klin Morphol Blutforsch 116 2 239 244 2475403 1:STN:280:DyaL1MzlslKrug%3D%3D (Pubitemid 19157512)
34. DA Triplett JT Brandt D Kaczor J Schaeffer 1983 Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure Am J Clin Pathol 79 6 678 682 6846258 1:STN:280:DyaL3s3gtFSktg%3D%3D (Pubitemid 13100731)
35. SE Blomgren JJ Condemi MC Bignall JH Vaughan 1969 Antinuclear antibody induced by procainamide. A prospective study N Engl J Med 281 2 64 66 4182059 10.1056/NEJM196907102810203 1:STN:280:DyaF1M3gsFerug%3D%3D
36. MR Bird AI O'Neill RR Buchanan KM Ibrahim PJ Des 1995 Lupus anticoagulant in the elderly may be associated with both quinine and quinidine usage Pathology 27 2 136 139 7567140 10.1080/00313029500169742 1:STN:280: DyaK28%2FitV2qsQ%3D%3D
37. CJ Lavie J Biundo RJ Quinet J Waxman 1985 Systemic lupus erythematosus (SLE) induced by quinidine Arch Intern Med 145 3 446 448 3977514 10.1001/archinte.1985.00360030078017 1:STN:280:DyaL2M7kvVamsg%3D%3D (Pubitemid 15140739)
38. RF Jeffrey 1986 Transient lupus anticoagulant and fansidar therapy Postgrad Med J 62 893 894 3101054 10.1136/pgmj.62.731.893 1:STN:280: DyaL2s7hsl2itw%3D%3D (Pubitemid 16012299)
39. RT Canoso RA Hutton D Deykin 1977 A chlorpromazine-induced inhibitor of blood coagulation Am J Hematol 2 2 183 191 888826 10.1002/ajh.2830020209 1:CAS:528:DyaE2sXlt1Omt7s%3D
40. S Zucker MH Zarrabi GS Romano F Miller 1978 IgM inhibitors of the contact activation phase of coagulation in chlorpromazine-treated patients Br J Haematol 40 3 447 457 749929 10.1111/j.1365-2141.1978.tb05816.x 1:CAS:528:DyaE1MXkvVKjtQ%3D%3D (Pubitemid 9027680)
41. MH Zarrabi S Zucker F Miller RM Derman GS Romano JA Hartnett, et al. 1979 Immunologic and coagulation disorders in chlorpromazine-treated patients Ann Intern Med 91 2 194 199 313732 1:STN:280:DyaE1M3jtVSjsQ%3D%3D (Pubitemid 10172176)
42. RT Canoso HS Sise 1982 Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities Am J Hematol 13 2 121 129 6814243 10.1002/ajh.2830130204 1:STN:280:DyaL3s%2FksFKmsA%3D%3D (Pubitemid 12009556)
43. G Tollefson K Rodysill M Cusulos 1984 A circulating lupus-like coagulation inhibitor induced by chlorpromazine J Clin Psychopharmacol 4 1 49 51 6420448 10.1097/00004714-198402000-00009 1:STN:280:DyaL2c7ht1Wlsw%3D%3D (Pubitemid 14157580)
44. GP Pavlidakey K Hashimoto GL Heller S Daneshvar 1985 Chlorpromazine- induced lupuslike disease. Case report and review of the literature J Am Acad Dermatol 13 1 109 115 2993378 10.1016/S0190-9622(85)70152-1 1:STN:280: DyaL2M3ptVSmtg%3D%3D (Pubitemid 15068688)
45. HE Zengotita RJ Holt 1986 Neuroleptic drug-induced coagulopathy: mechanism of reaction and duration of effect J Clin Psychiatry 47 1 35 37 3941056 1:STN:280:DyaL28%2FosFOiug%3D%3D (Pubitemid 16182759)
46. RT Canoso RM De Oliveira 1988 Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis Am J Hematol 27 272 275 3128108 10.1002/ajh.2830270408 1:STN:280:DyaL1c7otV2qsw%3D%3D
47. VD Steen R Ramsey-Goldman 1988 Phenothiazine-induced systemic lupus erythematosus with superior vena cava syndrome: case report and review of the literature Arthritis Rheum 31 7 923 926 3134899 10.1002/art.1780310716 1:STN:280:DyaL1c3otV2itA%3D%3D
48. RS el-Mallakh JO Donaldson HR Kranzler A Racy 1988 Phenothiazine- associated lupus anticoagulant and thrombotic disease Psychosomatics 29 1 109 113 3124190 10.1016/S0033-3182(88)72430-5 1:STN:280:DyaL1c7isFOnsA%3D%3D
49. B Jude J Goudemand I Dolle C Caron A Watel C Tiry, et al. 1988 Lupus anticoagulant: a clinical and laboratory study of 100 cases Clin Lab Haematol 10 41 51 3130214 1:STN:280:DyaL1c3htFSntw%3D%3D
50. DP Lillicrap M Pinto K Benford PM Ford S Ford 1990 Heterogeneity of laboratory test results for antiphospholipid antibodies in patients treated with chlorpromazine and other phenothiazines Am J Clin Pathol 93 771 775 1971739 1:STN:280:DyaK3c3ms1Oqsw%3D%3D (Pubitemid 20180937)
51. KA Kaslow RB Rosse JA Zeller MS Nagy SI Deustch 1992 Phenothiazine- induced lupus anticoagulant J Clin Psychiatry 53 3 103 104 1548247 1:STN:280:DyaK387ptlejsw%3D%3D
52. M Morgan CN Chesterman K Downs JC Biggs 1993 Clinical analysis of 125 patients with the lupus anticoagulant Aust N Z J Med 23 151 156 8517839 10.1111/j.1445-5994.1993.tb01809.x 1:STN:280:DyaK3s3pvVWjtA%3D%3D
53. 2-glycoprotein I on binding to phospholipid J Rheumatol 21 94 99 8151598 1:STN:280: DyaK2c3gt1Sqtg%3D%3D (Pubitemid 24044926)
54. B Tribout O Gosset V Fuentes S Gross P Fardelonne P Lernout, et al. 1995 High prevalence of antiphospholipid antibodies without increased risk of thrombosis in psychiatric patients treated chronically with neuroleptic drugs Nouv Rev Fr Hematol 37 S79 S82
55. Y Matsukawa M Satoh T Itoh S Nishinarita T Horie K Abe, et al. 1996 Plasmapheresis for a schizophrenic patient with drug-induced lupus anti-coagulant J Int Med Res 24 1 147 150 8674793 1:STN:280:DyaK283jtFWltw%3D%3D (Pubitemid 26060314)
56. LS Goldman JI Hudson WW Weddington Jr 1980 Lupus-like illness associated with chlorpromazine Am J Psychiatry 137 12 1613 1614 7435726 1:STN:280:DyaL3M%2FlvF2mtQ%3D%3D (Pubitemid 11196828)
57. EL Dubois E Tallman RA Wonka 1972 Chlorpromazine-induced systemic lupus erythematosus: case report and review of the literature JAMA 221 6 595 596 4114624 10.1001/jama.1972.03200190039010 1:STN:280:DyaE383js1Ghug%3D%3D
58. S Berglund CG Gottfries I Gottfries K Stormby 1970 Chlorpromazine-induced antinuclear factors Acta Med Scand 187 1-2 67 74 5310375 1:STN:280: DyaE3c3htlOgsg%3D%3D
59. RT Canoso JA Romero EJ Yunis 1986 Immunogenetic markers in chlorpromazine-induced tardive dyskinesia J Neuroimmunol 12 3 247 252 3090100 10.1016/S0165-5728(86)80008-X 1:STN:280:DyaL283nvVOqsw%3D%3D (Pubitemid 16049368)
60. G Kahn BP Davis 1970 In vitro studies on longwave ultraviolet light-dependent reactions of the skin photosensitizer chlorpromazine with nucleic acids, purines and pyrimidines J Invest Dermatol 55 1 47 52 5425066 10.1111/1523-1747.ep12290532 1:CAS:528:DyaE3cXks1amur0%3D
61. A Kanjolia JM Valigorsky ML Joson-Pasion 1997 Clozaril-induced lupus anticoagulant Am J Hematol 54 4 345 346 9092703 10.1002/(SICI)1096-8652(199704) 54:4<345::AID-AJH21>3.0.CO;2-9 1:STN:280:DyaK2s3ks1Cltw%3D%3D (Pubitemid 27160878)
62. D Alarcon-Segovia E Fishbein PA Reyes H Dies S Shwadsky 1972 Antinuclear antibodies in patients on anticonvulsant therapy Clin Exp Immunol 12 1 39 47 4117275 1:STN:280:DyaE3s%2Fjt1CqtA%3D%3D
63. DH Beernink JJ Miller III 1973 Anticonvulsant-induced antinuclear antibodies and lupus-like disease in children J Pediatr 82 1 113 117 4564576 10.1016/S0022-3476(73)80027-7 1:STN:280:DyaE3s%2FkvVKksA%3D%3D
64. BH Singsen L Fishman V Hanson 1976 Antinuclear antibodies and lupus-like syndromes in children receiving anticonvulsants Pediatrics 57 4 529 534 1083501 1:STN:280:DyaE287nsFCjtg%3D%3D
65. VE Drory AD Korczyn 1993 Hypersensitivity vasculitis and systemic lupus erythematosus induced by anticonvulsants Clin Neuropharmacol 16 1 19 29 8422654 10.1097/00002826-199302000-00002 1:STN:280:DyaK3s7jslagtw%3D%3D (Pubitemid 23028494)
66. RL Harrison JB Alperin D Kumar 1987 Concurrent lupus anticoagulants and prothrombin deficiency due to phenytoin use Arch Pathol Lab Med 111 719 722 3115223 1:STN:280:DyaL2szisFCrtw%3D%3D (Pubitemid 17127178)
67. JC Becker B Winkler S Klingert EB Brocker 1994 Antiphospholipid syndrome associated with immunotherapy for patients with melanoma Cancer 73 6 1621 1624 8156489 10.1002/1097-0142(19940315)73:6<1621::AID-CNCR2820730613>3.0.CO;2- E 1:STN:280:DyaK2c3gsl2gtg%3D%3D (Pubitemid 24085261)
68. RB Stricker B Barlogie DD Kiprov 1994 Acquired factor VIII inhibitor associated with chronic interferon-alpha therapy J Rheumatol 21 2 350 352 8182649 1:STN:280:DyaK2c3jvVGrtg%3D%3D (Pubitemid 24078853)
69. G Ferraccioli F Mecchia PE Di M Fabris 2002 Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections Ann Rheum Dis 61 4 358 361 11874843 10.1136/ard.61.4.358 1:CAS:528: DC%2BD38XjtVertbw%3D (Pubitemid 34257750)
70. C Ferraro-Peyret F Coury JG Tebib J Bienvenu N Fabien 2004 Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study Arthritis Res Ther 6 6 R535 R543 15535831 10.1186/ar1440 1:CAS:528:DC%2BD2cXpt1ajsb4%3D
71. S Visvanathan C Wagner J Smolen EW St Clair R Hegedus D Baker, et al. 2006 IgG and IgM anticardiolipin antibodies following treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis Arthritis Rheum 54 9 2840 2844 16948115 10.1002/art.22054 1:CAS:528:DC%2BD28XhtFWksLjE (Pubitemid 44497762)
72. DA Wetter MD Davis 2009 Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic Mayo Clin Proc 84 11 979 984 19880688 10.4065/84.11.979 1:CAS:528:DC%2BD1MXhsVGms7vN
73. A Makol M Grover C Guggenheim H Hassouna 2010 Etanercept and venous thromboembolism: a case series J Med Case Reports 4 12 20157435 10.1186/1752-1947-4-12
74. A Nosbaum C Goujon B Fleury I Guillot JF Nicolas F Berard 2007 Arterial thrombosis with anti-phospholipid antibodies induced by infliximab Eur J Dermatol 17 6 546 547 17951145 (Pubitemid 350207176)
75. E Vereckei G Krivan M Reti P Szodoray G Poor E Kiss 2010 Anti-TNF-alpha-induced anti-phospholipid syndrome manifested as necrotizing vasculitis Scand J Rheumatol 39 2 175 177 20337548 10.3109/03009740902832753
76. M Ramos-Casals P Brito-Zeron MJ Soto MJ Cuadrado MA Khamashta 2008 Autoimmune diseases induced by TNF-targeted therapies Best Pract Res Clin Rheumatol 22 5 847 861 19028367 10.1016/j.berh.2008.09.008 1:CAS:528: DC%2BD1cXhsVWmt7rM
77. PA Merkel GH Lo JT Holbrook AK Tibbs NB Allen JC Davis Jr, et al. 2005 Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study Ann Intern Med 142 8 620 626 15838068 (Pubitemid 40529958)
78. JK Sebastian B Voetsch JH Stone Z Romay-Penabad GH Lo NB Allen, et al. 2007 The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event J Rheumatol 34 12 2446 2450 17918782 (Pubitemid 350230669)
79. R Davies JB Galloway KD Watson M Lunt DP Symmons KL Hyrich 2011 Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register Ann Rheum Dis 70 10 1831 1834 21784722 10.1136/ard.2011. 153536 1:CAS:528:DC%2BC3MXhtl2rsrzL
80. M Boxer L Ellman A Carvalho 1976 The lupus anticoagulant Arthritis Rheum 19 6 1244 1248 999735 10.1002/art.1780190603 1:STN:280:DyaE2s%2FmsFentg%3D%3D
81. N Yokogawa FB Vivino 2009 Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis Mod Rheumatol 19 3 338 347 19424772 10.1007/s10165-009-0168-y
82. DJ Orris JH Lewis JA Spero U Hasiba 1980 Blocking coagulation inhibitors in children taking penicillin J Pediatr 97 3 426 429 7411305 10.1016/S0022-3476(80)80195-8 1:STN:280:DyaL3M%2FgvV2htQ%3D%3D (Pubitemid 11225850)
83. GM Brodeur PJ O'Neill JA Willimas 1980 Acquired inhibitors of coagulation in nonhemophiliac children J Pediatr 96 3 Pt 1 439 441 7359239 1:STN:280:DyaL3c7jvFGntg%3D%3D (Pubitemid 10147539)
84. T Vyse AK So 1992 Sulphasalazine induced autoimmune syndrome Br J Rheumatol 31 2 115 116 1346581 10.1093/rheumatology/31.2.115 1:STN:280:DyaK387ksFaqtw%3D%3D
85. D Alarcon-Segovia 1969 Drug-induced lupus syndromes Mayo Clin Proc 44 9 664 681 4898319 1:STN:280:DyaF1M3pvVeisg%3D%3D
86. 2-glycoprotein I antibody affinity J Immunol 161 4 2038 2043 9712077 1:CAS:528:DyaK1cXltlKqsLk%3D (Pubitemid 28387630)
87. 2-glycoprotein I (apolipoprotein H) Proc Natl Acad Sci USA 87 4120 4124 2349221 10.1073/pnas.87.11.4120 1:CAS:528:DyaK3cXktlymtbo%3D (Pubitemid 20217993)
88. B Uchman DA Triplett 1989 Inhibitor effect of polymyxin B on the X-ase and prothrombinase complex formation Thromb Haemost 62 375 Ref Type: Abstract
89. JT Brandt LK Barna DA Triplett 1995 Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH Thromb Haemost 74 6 1597 1603 8772243 1:CAS:528:DyaK28Xjtlynuw%3D%3D (Pubitemid 26018092)
90. Y Cajal J Ghanta K Easwaran A Surolia MK Jain 1996 Specificity for the exchange of phospholipids through polymyxin B mediated intermembrane molecular contacts Biochemistry 35 18 5684 5695 8639528 10.1021/bi952703c 1:CAS:528:DyaK28XitlWqsbY%3D (Pubitemid 26143664)
91. Packman CH, Leddy JP. Drug-related immune hemolytic anemia. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, editors. Williams Hematology. New York: McGraw-Hill; 1995. p. 691-7.
92. A Kornberg L Silber R Yona S Kaufman 1989 Clinical manifestations and laboratory findings in patients with lupus anticoagulants Eur J Haematol 42 90 95 2914599 10.1111/j.1600-0609.1989.tb00253.x 1:STN:280:DyaL1M7itFSlsQ%3D%3D (Pubitemid 19044714)
93. M Sanmarco C Soler C Christides D Raoult PJ Weiller V Gerolami, et al. 1997 Prevalence and clinical significance of IgG isotype anti-beta-2- glycoprotein I antibodies in antiphospholipid syndrome: a comparative study with anticardiolipin antibodies J Lab Clin Med 129 5 499 506 9142046 10.1016/S0022-2143(97)90004-4 1:STN:280:DyaK2s3os12mtg%3D%3D (Pubitemid 27285046)